What is Bicara Therapeutics's taxes paid?

Bicara Therapeutics (BCAX) reported taxes paid of $0 in Q1 2026.

How has Bicara Therapeutics's taxes paid changed year-over-year?

Bicara Therapeutics's taxes paid decreased by 100.0% year-over-year, from $72K to $0.

What does taxes paid mean?

Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.

Bicara Therapeutics BCAX Taxes Paid

Taxes Paid at other companies

Inhibrx Biosciences, Inc.INBX

$0—

Nuvation BioNUVB

$49.25K-47.2%

Immunovant, Inc.IMVT

$1.64M—

Natera, Inc.NTRA

$124.75K-61.8%

Aurinia PharmaceuticalsAUPH

$1.33M+439%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaid.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's taxes paid?: Bicara Therapeutics (BCAX) reported taxes paid of $0 in Q1 2026.
How has Bicara Therapeutics's taxes paid changed year-over-year?: Bicara Therapeutics's taxes paid decreased by 100.0% year-over-year, from $72K to $0.
What does taxes paid mean?: Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.